InsiderClue
← All stocks

PHIBRO ANIMAL HEALTH CORP

PAHC Mostly scheduled
CIK 0001069899 #2275 in the set updated 18 Sep 2026
Bought (12 mo)
$317.70K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$31.15M
$24.81M on a plan · $6.33M straight out of an exercise
Sold at will
$0.00
0 of 119 sales
Net
−$30.83M
+$317.70K against sales at will

By person

10 insiders · 120 transactions
1.0×

Jack C. Bendheim holds only 1.0 times base salary in stock. $2.63M of shares against $2.44M in salary for 2025.

Salary from the company's own proxy. The shares are what Jack C. Bendheim last reported holding, valued at $31.77, the price Class A Common Stock was last bought or sold at on the open market here, on 29 May 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BENDHEIM JACK
Executive Chairman
—
$31.15M (119) scheduled
−$31.15M
82,792
0.204%
$2.63M
+39.2%
CORCORAN E THOMAS
Director
$317.70K (1)
—
+$317.70K
41,459
0.102%
$1.32M
+56.7%
David Glenn
Chief Financial Officer
—
—
—
54,811
0.135%
$1.74M
—
Miller Larry Lee
Chief Operating Officer
—
—
—
38,071
0.094%
$1.21M
+26.9%
Bendheim Daniel M
President and CEO
—
—
—
15,177
0.037%
$482.17K
—
BENDHEIM Jonathan
Director
—
—
—
5,984
0.015%
$190.11K
—
Weinstein Judith
See Remarks
—
—
—
5,453
0.013%
$173.24K
—
Escudero Lisa Ann
See Remarks
—
—
—
3,434
0.008%
$109.10K
—
Andolino Anthony
See Remarks
—
—
—
1,793
0.004%
$56.96K
—
Rodriguez Patrick
VP Finance and Treasurer
—
—
—
1,503
0.004%
$47.75K
—

Individual transactions

1
Insider
Date
Role
Action
Shares
Price
Amount
CORCORAN E THOMAS
29 May 2026
Director
Buy
10,000
$31.77
$317.70K
Show all 120 transactions →

What was left out

Form 4 filings counted 52
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 37
Sales on a Rule 10b5-1 plan 105
Sales straight out of an exercise 14
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 756,431
History held since 14 Nov 2016